Attachment

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl 2021-0023 CTA - Clinical Trial Agreement 1/27/2021 NeuroRx H Clifford Lane 2021-0040 CTA - Clinical Trial Agreement 4/16/2021 Molecular Partners AG [CH] H Clifford Lane 2021-0040 CTA - Clinical Trial Agreement 4/16/2021 NOVARTIS PHARMA AG H Clifford Lane 2021-0072 Research Collaboration Agreement 5/20/2021] 5/20/2024|Icahn School of Medicine at Mount Sinai Joseph Marcotrigi 2021-0077 Letter of Intent/MOU 2/26/2021] 12/31/2024|Genentech, Inc. Yasmine Belkaid 2021-0079 Research Collaboration Agreement 5/17/2021] 5/17/2022|Signify Health Vincent Munster 2021-0091 Letter of Intent/MOU 3/11/2021) Tokyo Medical and Dental University [JP] John Beigel 2021-0187 Research Collaboration Agreement 3/15/2022] 3/31/2025|The University of Adelaide [AU] Sonja Best 2021-0194 CTA - Clinical Trial Agreement 4/26/2021 Pfizer, Inc. H Clifford Lane Merck & Co., Inc. (currently Merck, Sharp, and 2021-0272 CRADA 9/30/2022] 9/30/2025|Dohme) Jessica Manning Merck & Co., Inc. (currently Merck, Sharp, and 2021-0273 CRADA 1/4/2023 1/4/2026] Dohme) Jessica Manning Cincinnati Children's Hospital Medical Center, 2021-0287 Research Collaboration Agreement 3/23/2022| 3/23/2027|Northwestern University, University of Utah Amy Klion Cincinnati Children's Hospital Medical Center, 2021-0287 Research Collaboration Agreement 3/23/2022| 3/23/2027|Northwestern University, University of Utah Amy Klion 2021-0288 Research Collaboration Agreement 7/8/2021 7/8/2026} University of Malaya Png Loke 2021-0288 Research Collaboration Agreement 7/8/2021 7/8/2026} University of Malaya Png Loke 2021-0311 Research Collaboration Agreement 8/25/2021| 8/27/2024|Rutgers New Jersey Medical School [US] Ursula Buchholz 2021-0312 Research Collaboration Agreement 7/23/2021 8/5/2024] Kansas State University Ursula Buchholz Foundation for the National Institutes of Health, 2021-0319 Gift 8/20/2021] 7/24/2022|Inc. (FNIH), NYU Langone Medical Center Elodie Ghedin 2021-0379 Research Collaboration Agreement 5/26/2021] 5/26/2024]Food and Drug Administration (FDA) Mathew Memoli 2021-0394 CTA - Clinical Trial Agreement 2/8/2022) Cincinnati Children's Hospital Medical Center Amy Klion 2021-0394 CTA - Clinical Trial Agreement 2/8/2022, Cincinnati Children's Hospital Medical Center Amy Klion 2021-0432 CTA - Clinical Trial Agreement 5/7/2021) Jasper Therapeutics Harry Malech 2021-0432 CTA - Clinical Trial Agreement 5/7/2021 Jasper Therapeutics Harry Malech University of Oxford (incl Isis Innovation, The 2021-0502 Research Collaboration Agreement 12/7/2021] 12/7/2026|Chancellor, Masters and Scholars Png Loke University of Oxford (incl Isis Innovation, The 2021-0502 Research Collaboration Agreement 12/7/2021] 12/7/2026}Chancellor, Masters and Scholars Png Loke University of Oxford (incl Isis Innovation, The 2021-0502 Research Collaboration Agreement 12/7/2021] 12/7/2026}|Chancellor, Masters and Scholars Png Loke